Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040416 | SCV000064107 | uncertain significance | not specified | 2019-12-20 | criteria provided, single submitter | clinical testing | The p.Arg17137Cys variant in TTN has been identified by our laboratory in 1 African American individual with RCM and a dilated left atrium who also carried a pathogenic variant in another gene that most likely explained their disease. This variant has also been identified in 0.04% (15/35302) of Latino chromosomes by the gnomAD (https://gnomad.broadinstitute.org). Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Arg17137Cys variant is uncertain. |
Gene |
RCV000725816 | SCV000237350 | likely benign | not provided | 2019-11-05 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 30924900, 26567375) |
Eurofins Ntd Llc |
RCV000725816 | SCV000339584 | uncertain significance | not provided | 2018-01-24 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000469250 | SCV000542455 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-12-13 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852513 | SCV000995209 | uncertain significance | Long QT syndrome | 2018-06-05 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000725816 | SCV001475786 | uncertain significance | not provided | 2020-02-20 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000040416 | SCV002074509 | likely benign | not specified | 2022-01-31 | criteria provided, single submitter | clinical testing | Variant summary: TTN c.51409C>T (p.Arg17137Cys) results in a non-conservative amino acid change located in the A-band region of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00024 in 248286 control chromosomes, predominantly at a frequency of 0.00044 within the Latino subpopulation in the gnomAD database. The observed variant frequency within Latino control individuals in the gnomAD database is slightly higher than the estimated maximal expected allele frequency for a pathogenic variant in TTN causing Dilated Cardiomyopathy phenotype (0.00039), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Latino origin. c.51409C>T has been reported in the literature in individuals affected with different Cardiomyopathies (Begay_2015, Klauke_2017). In a family reported by Klauke_2017, two sisters with arrhythmogenic right ventricular cardiomyopathy were genotyped; one sister carried this variant and the other sister carried the reference allele, showing the variant did not segregate with the disease phenotype. These siblings also carried other pathogenic variants (PLN c.40_42delAGA, p.Arg14del) which segregated with disease, providing supporting evidence for a benign role of TTN c.51409C>T. An undisclosed pathogenic co-occurence was also reported by ClinVar submitter "Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine" (Accession: SCV000064107.7). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Seven ClinVar submitters have assessed the variant since 2014: five classified the variant as of uncertain significance and two as likely benign. Based on the evidence outlined above, the variant was classified as likely benign. |
Ambry Genetics | RCV002321523 | SCV002609623 | likely benign | Cardiovascular phenotype | 2019-09-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Institut für Laboratoriums- |
RCV000491963 | SCV000298155 | likely benign | Arrhythmogenic right ventricular dysplasia 9 | 2016-05-01 | no assertion criteria provided | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000725816 | SCV001980481 | likely benign | not provided | no assertion criteria provided | clinical testing |